scholarly article | Q13442814 |
P50 | author | Sergey Netesov | Q4317976 |
Janusz Pawęska | Q59679669 | ||
John M Dye | Q62478445 | ||
Elke Mühlberger | Q66680053 | ||
Jonathan S Towner | Q87983083 | ||
Ayato Takada | Q20041094 | ||
Erica Ollmann Saphire | Q28320547 | ||
Jens H. Kuhn | Q37367553 | ||
Viktor Volchkov | Q39034329 | ||
Hideki Ebihara | Q54008242 | ||
Eric M Leroy | Q56379732 | ||
Kartik Chandran | Q56433316 | ||
P2093 | author name string | Travis K Warren | |
Olga Dolnik | |||
Sophie J Smither | |||
Jean L Patterson | |||
Alexander A Bukreyev | |||
P2860 | cites work | Discovery of an ebolavirus-like filovirus in europe | Q21003881 |
Newly discovered ebola virus associated with hemorrhagic fever outbreak in Uganda | Q21090519 | ||
Proposal for a revised taxonomy of the family Filoviridae: classification, names of taxa and viruses, and virus abbreviations | Q24620453 | ||
Ratification vote on taxonomic proposals to the International Committee on Taxonomy of Viruses (2012) | Q28263889 | ||
On the etiology of an unknown human infection originating from monkeys | Q34205821 | ||
Isolation and partial characterisation of a new virus causing acute haemorrhagic fever in Zaire | Q34263587 | ||
Phylogenetic assessment of filoviruses: how many lineages of Marburg virus? | Q36209292 | ||
PAirwise Sequence Comparison (PASC) and its application in the classification of filoviruses | Q36246800 | ||
Virus nomenclature below the species level: a standardized nomenclature for natural variants of viruses assigned to the family Filoviridae | Q36504020 | ||
Virus nomenclature below the species level: a standardized nomenclature for laboratory animal-adapted strains and variants of viruses assigned to the family Filoviridae | Q36893352 | ||
Genetics-based classification of filoviruses calls for expanded sampling of genomic sequences | Q40267312 | ||
A proposal to change existing virus species names to non-Latinized binomials | Q45372294 | ||
P433 | issue | 4 | |
P921 | main subject | Filoviridae | Q46305 |
urban ecology | Q1430301 | ||
P1104 | number of pages | 10 | |
P304 | page(s) | 821-830 | |
P577 | publication date | 2014-04-01 | |
P1433 | published in | Archives of Virology | Q2860564 |
P1476 | title | Discussions and decisions of the 2012–2014 International Committee on Taxonomy of Viruses (ICTV) Filoviridae Study Group, January 2012–June 2013. | |
P478 | volume | 159 |
Q92704046 | A Chimeric Sudan Virus-Like Particle Vaccine Candidate Produced by a Recombinant Baculovirus System Induces Specific Immune Responses in Mice and Horses |
Q40180287 | A polymorphism of the TIM-1 IgV domain: implications for the susceptibility to filovirus infection. |
Q90037971 | Accounting for population structure reveals ambiguity in the Zaire Ebolavirus reservoir dynamics |
Q35840026 | Analytical Performance Characteristics of the Cepheid GeneXpert Ebola Assay for the Detection of Ebola Virus |
Q30148647 | Animal Models of Ebolavirus Infection |
Q64359301 | Complete Genome Sequence of a New Ebola Virus Strain Isolated during the 2017 Likati Outbreak in the Democratic Republic of the Congo |
Q27681924 | Crystal Structure of Marburg Virus VP24 |
Q91809887 | Development and Evaluation of a Duo Zaire ebolavirus Real-Time RT-PCR Assay Targeting Two Regions within the Genome |
Q59352651 | Distinct Biological Phenotypes of Marburg and Ravn Virus Infection in Macaques |
Q51784219 | Distinct Immunogenicity and Efficacy of Poxvirus-based Vaccine Candidates against Ebola Virus expressing GP and VP40 Proteins. |
Q89497416 | Duplicate US1 Genes of Duck Enteritis Virus Encode a Non-essential Immediate Early Protein Localized to the Nucleus |
Q30251949 | Ebola Virus Infection: Review of the Pharmacokinetic and Pharmacodynamic Properties of Drugs Considered for Testing in Human Efficacy Trials |
Q38231522 | Ebola and Marburg virus diseases in Africa: increased risk of outbreaks in previously unaffected areas? |
Q62477474 | Ebola virus disease |
Q35234172 | Ebola virus disease 2013-2014 outbreak in west Africa: an analysis of the epidemic spread and response |
Q34527039 | Ebolavirus Database: Gene and Protein Information Resource for Ebolaviruses |
Q93145910 | Filovirus Disease Outbreaks: A Chronological Overview |
Q42934343 | Filovirus RefSeq entries: evaluation and selection of filovirus type variants, type sequences, and names |
Q40050992 | Guide to the Correct Use of Filoviral Nomenclature |
Q90086197 | Host factor SMYD3 is recruited by Ebola virus nucleoprotein to facilitate viral mRNA transcription |
Q42343682 | Implementation of Objective PASC-Derived Taxon Demarcation Criteria for Official Classification of Filoviruses |
Q90475117 | Improving immunological insights into the ferret model of human viral infectious disease |
Q30386606 | Interaction between TIM-1 and NPC1 Is Important for Cellular Entry of Ebola Virus. |
Q40114945 | Laboratory diagnosis of Ebola virus disease and corresponding biosafety considerations in the China Ebola Treatment Center |
Q36012840 | Large-Scale Screening and Identification of Novel Ebola Virus and Marburg Virus Entry Inhibitors |
Q27015752 | Marburg Virus Reverse Genetics Systems |
Q30277312 | Molecular architecture of the nucleoprotein C-terminal domain from the Ebola and Marburg viruses |
Q35193304 | Multiplex nucleic acid suspension bead arrays for detection and subtyping of filoviruses |
Q28383265 | Neglected filoviruses |
Q34580917 | Nomenclature- and database-compatible names for the two Ebola virus variants that emerged in Guinea and the Democratic Republic of the Congo in 2014. |
Q38785678 | Novel activities by ebolavirus and marburgvirus interferon antagonists revealed using a standardized in vitro reporter system |
Q35871655 | Precise genotyping and recombination detection of Enterovirus |
Q45346814 | Production and Purification of Filovirus Glycoproteins in Insect and Mammalian Cell Lines |
Q38765575 | RNA Binding of Ebola Virus VP30 Is Essential for Activating Viral Transcription |
Q38643841 | Recent advances in the development of vaccines for Ebola virus disease |
Q35654347 | Risk Factors Associated with Ebola and Marburg Viruses Seroprevalence in Blood Donors in the Republic of Congo |
Q38836977 | Rodent-Adapted Filoviruses and the Molecular Basis of Pathogenesis |
Q92901041 | Scalable, semi-automated fluorescence reduction neutralization assay for qualitative assessment of Ebola virus-neutralizing antibodies in human clinical samples |
Q38666317 | Small Animal Models for Studying Filovirus Pathogenesis |
Q57291140 | Staufen1 Interacts with Multiple Components of the Ebola Virus Ribonucleoprotein and Enhances Viral RNA Synthesis |
Q30376138 | The multifunctional Ebola virus VP40 matrix protein is a promising therapeutic target. |
Q39010678 | The roles of ebolavirus glycoproteins in viral pathogenesis. |
Q38980947 | Therapeutics for postexposure treatment of Ebola virus infection |
Q38258245 | Tissue and cellular tropism, pathology and pathogenesis of Ebola and Marburg viruses |
Q91024578 | Towards quantification of protective antibody responses by passive transfer of the 1st WHO International Standard for Ebola virus antibody in a guinea pig model |
Q38584603 | Viral bioterrorism: Learning the lesson of Ebola virus in West Africa 2013-2015. |
Q40119980 | Visual detection of Ebola virus using reverse transcription loop-mediated isothermal amplification combined with nucleic acid strip detection |
Search more.